Similar articles

• Importance of biopharmaceutics and pharmacokinetics in clinical medicine.

  Cabana BE. Cabana BE. Arzneimittelforschung. 1976;26(1A):151-8. Arzneimittelforschung. 1976. PMID: 947194
• [Bioavailability, proof of efficacy and their consequences for drug legislation (author's transl)].

  Schnieders B. Schnieders B. Arzneimittelforschung. 1976;26(1A):158-63. Arzneimittelforschung. 1976. PMID: 947195 German.
• Bioavailability of drugs (first of two parts).

  Koch-Weser J. Koch-Weser J. N Engl J Med. 1974 Aug 1;291(5):233-7. doi: 10.1056/NEJM197408012910505. N Engl J Med. 1974. PMID: 4600408 Review. No abstract available.
• Guidelines for evaluation of drugs for use in man. Report of a WHO scientific group.

  [No authors listed] [No authors listed] World Health Organ Tech Rep Ser. 1975;(563):1-59. World Health Organ Tech Rep Ser. 1975. PMID: 803745 Clinical Trial. No abstract available.
• Bioavailability of drugs (second of two parts).

  Koch-Weser J. Koch-Weser J. N Engl J Med. 1974 Sep 5;291(10):503-6. doi: 10.1056/NEJM197409052911005. N Engl J Med. 1974. PMID: 4604153 Review. No abstract available.